- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 7/02 - Linear peptides containing at least one abnormal peptide link
Patent holdings for IPC class C07K 7/02
Total number of patents in this class: 654
10-year publication summary
|
47
|
48
|
37
|
66
|
72
|
50
|
59
|
61
|
37
|
11
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1144 |
76 |
| Protagonist Therapeutics, Inc. | 124 |
21 |
| SeaGen Inc | 554 |
15 |
| Centre National de La Recherche Scientifique | 9632 |
13 |
| CARA Therapeutics, Inc. | 73 |
12 |
| Shenzhen HighTide Biopharmaceutical, Ltd. | 47 |
9 |
| University of South Florida | 1817 |
8 |
| Pfizer Inc. | 3322 |
7 |
| Takeda Pharmaceutical Company Limited | 2961 |
7 |
| L.e.a.f. Holdings Group LLC | 93 |
7 |
| Mersana Therapeutics, Inc. | 106 |
7 |
| Novartis AG | 11238 |
6 |
| The Regents of the University of California | 18943 |
6 |
| Wisconsin Alumni Research Foundation | 3774 |
6 |
| Genentech, Inc. | 3742 |
5 |
| Deutsches Krebsforschungszentrum | 417 |
5 |
| On Target Laboratories, LLC | 37 |
5 |
| Sarepta Therapeutics, Inc. | 353 |
5 |
| Bicyclerd Limited | 130 |
5 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
4 |
| Other owners | 425 |